Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Life Sciences (2151)
- Medical Specialties (2151)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (29)
- Chemicals and Drugs (15)
- Diseases (15)
-
- Health Services Research (15)
- Psychiatry and Psychology (11)
- Surgical Procedures, Operative (6)
- Anesthesiology (4)
- Bacteria (4)
- Female Urogenital Diseases and Pregnancy Complications (4)
- Nursing (4)
- Organisms (4)
- Anatomy (3)
- Dentistry (3)
- Diagnosis (3)
- Medical Education (3)
- Rehabilitation and Therapy (3)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
- Dietetics and Clinical Nutrition (2)
- Gastroenterology (2)
- Health and Medical Administration (2)
- Mental and Social Health (2)
- Respiratory System (2)
- Bacterial Infections and Mycoses (1)
- Communication Sciences and Disorders (1)
- Dermatology (1)
- Enzymes and Coenzymes (1)
- Keyword
- Publication Year
- Publication Type
Articles 1 - 30 of 2166
Full-Text Articles in Public Health
Patient Involvement And Communication Council, Angela Murphy, Laura Gooseberry, Becca Austin, Rob Behrendt, Lara Miskevich
Patient Involvement And Communication Council, Angela Murphy, Laura Gooseberry, Becca Austin, Rob Behrendt, Lara Miskevich
2023 Patient Advisor Retreat
Patient-Centered Care (nothing about me without me) is the best approach to improve outcomes and provide value to each patient. The Council is involved in the following: Act as champions of patient experience andbring ideas, thoughts, and opinions on various topics and processes. Review patient and family communications to ensure engagement in health care services. Provide feedback regarding communication gaps between patients and providers. Revise and improve materials to be understood by patients and their caregivers.
Using Storytelling To Share Lived Experiences With Maternal Mental Health (Mama), Sara Santarossa, Amy Loree, Courtney Latimer, Wendy Corriveau, Sara Mertz, Hailey Maddox, Leah M. Copeland, Dana Murphy, Ashley B. Redding
Using Storytelling To Share Lived Experiences With Maternal Mental Health (Mama), Sara Santarossa, Amy Loree, Courtney Latimer, Wendy Corriveau, Sara Mertz, Hailey Maddox, Leah M. Copeland, Dana Murphy, Ashley B. Redding
2023 Patient Advisor Retreat
Mental health conditions are a top medical complication of pregnancy and childbirth and are associated with a range of adverse maternal and child outcomes. Approximately 1 in 7 to 1 in 4 birthing people experience symptoms of a mental health condition during pregnancy or postpartum, yet few are diagnosed or treated. There remain critical knowledge gaps and significant challenges to adequately addressing maternal mental health. Project aims to use storytelling to share diverse perspectives on MAternal MentAl health (MAMA), build capacity and engagement for patient centered research by sharing these stories in a Storytelling Symposium, and with the aid of …
Bump: Burnout Mitigation In Physician Trainees, Jacqueline Pflaum-Carlson, Sara Santarossa, Lisa Mclean, Julie A. Hamilton, Dana Murphy, Ashley B. Redding
Bump: Burnout Mitigation In Physician Trainees, Jacqueline Pflaum-Carlson, Sara Santarossa, Lisa Mclean, Julie A. Hamilton, Dana Murphy, Ashley B. Redding
2023 Patient Advisor Retreat
Physician burnout affects healthcare organizations at every level and has been associated with higher self-reported errors, increased turnover, and has a negative impact on patient care; it is estimated that tens of thousands of Americans die each year as a result ofpreventable medical errors. This project seeks to reduce the symptoms of physician burnout by exploring Acceptance Commitment Therapy (ACT) compared to Body Mapping as effective interventions in preventing and mitigating burnout in physician trainees at Henry Ford Health (HFH) in Detroit, Michigan.
Our Contributions To The Hermelin Brain Tumor Center (Hbtc), Megan Sauer, Marc Betman, Ron Leach, Mike Coughlin, Jeni Barry, Dominik Mackowski, Lisa Scarpace, Nestelynn Gay
Our Contributions To The Hermelin Brain Tumor Center (Hbtc), Megan Sauer, Marc Betman, Ron Leach, Mike Coughlin, Jeni Barry, Dominik Mackowski, Lisa Scarpace, Nestelynn Gay
2023 Patient Advisor Retreat
The Hermelin Brain Tumor Center Patient and Family Advisory Council is comprised of patients and care partners who have generously agreed to come together to share their experiences and ideas. Mission Statement: Our goal is to drive patient and caregiver education, innovation, research, and success to continue to be a center of excellence. We aim to amplify the strengths of the Hermelin Brain Tumor Center by sharing our combined experience as patients, caregivers, and clinicians to its continual improvement and development.
Pursuing Equity In Patient Care (Pepc), Linda Stechison, Jaquetta Hinton, Marla R. Gorosh, Kimberleydawn Wisdom
Pursuing Equity In Patient Care (Pepc), Linda Stechison, Jaquetta Hinton, Marla R. Gorosh, Kimberleydawn Wisdom
2023 Patient Advisor Retreat
Participating on the PEPC Committee is an opportunity to observe the exchange of information with leaders who are in positions to act on Quality Improvement (QI) projects/clinical research(CR) results to expand scope, encourage spread, and share resources. As Patient Advisors we use the lenses of our personal identities, work history, and life experiences to provide perspective for the patients’ voices. We see the barriers of the patient-clinician relationship that don’t address the power differential and make assumptions (unconscious bias) that affect adherence and outcomes of care.
Steps Pfac: Seniors Using Technology To Engage In Pain Self-Management, Lisa D. Landvogt, Leslie Grijalva, Tracie Mason, Jessica Judson, Courtney Latimer, Jaye Clement, Kimberlydawn Widsom, Tashfia Jilu, Sara Nguyen, Rebecca Lindsay, Mary Javenic
Steps Pfac: Seniors Using Technology To Engage In Pain Self-Management, Lisa D. Landvogt, Leslie Grijalva, Tracie Mason, Jessica Judson, Courtney Latimer, Jaye Clement, Kimberlydawn Widsom, Tashfia Jilu, Sara Nguyen, Rebecca Lindsay, Mary Javenic
2023 Patient Advisor Retreat
STEPS stands for Seniors using Technology to Engage in Pain Self-management. We are testing to see if a pain self-management program can help people live better with chronic pain and reduce pain’s impact on their lives. Participants will: Complete three 60-minute telephone surveys Baseline, 2-month follow-up, and 12-month follow-up. Be randomly placed into one of two groups (50/50 chance): Intervention Group: A 7-week program with web-based videos and weekly telephone sessions led by a Community Health Worker. Control Group: A control group that receives program materials & a half-day workshop after the final survey.
Experienced Transformation Patient & Family Advisory Council, John Bollinger, Thomas Eisenmann, Missy Ewald, Julie Goldstein-Dunn, Ally Hunter, Jennifer Kindseth, Shivani Mehta, Vanessa Mona, Stephanie Ryan, Courtney Stevens, Rajitha Viswaraju
Experienced Transformation Patient & Family Advisory Council, John Bollinger, Thomas Eisenmann, Missy Ewald, Julie Goldstein-Dunn, Ally Hunter, Jennifer Kindseth, Shivani Mehta, Vanessa Mona, Stephanie Ryan, Courtney Stevens, Rajitha Viswaraju
2023 Patient Advisor Retreat
Providing Patient-Centered Care (Nothing about me without me) is the best approach to improving outcomes and providing value to each patient. This council works on initiatives and process improvement around pre-visit, onsite visit, and post-visit communication and delivery. Additional Henry Ford Health priorities are to leverage existing or new digital solutions that facilitate patient access, strengthen existing referral channels and growing new ones with potential future partners, assist patients with understanding and paying their health expenses, and better manage total per member per month cost through patient/member engagement in their wellness and care.
Improving Research Is A Multipronged Collaborative Approach Reliant On "Expert" Humility And Respect, Philip Cheng, Andrew Bossick, Ashley B. Redding
Improving Research Is A Multipronged Collaborative Approach Reliant On "Expert" Humility And Respect, Philip Cheng, Andrew Bossick, Ashley B. Redding
2023 Patient Advisor Retreat
Our project goal is to bring together Henry Ford health sciences researchers and community members to promote the engagement of diverse patient perspectives. This poster highlights current initiatives pertaining to the integration of diverse perspectives into the research process to enhance our science at the group, system, and NIH level.
All Of Us Research Program Pfac, Janine Hussein, Tiffany S. Lee, Cathy Peltz, Christine C. Johnson, Brian Ahmedani
All Of Us Research Program Pfac, Janine Hussein, Tiffany S. Lee, Cathy Peltz, Christine C. Johnson, Brian Ahmedani
2023 Patient Advisor Retreat
The goal of the All of Us Research Program (AoURP) is to help improve the future of health by accelerating health research and medical breakthroughs. The AoURPis part of the National Institutes of Health (NIH) Precision Medicine Initiative and seeks to help researchers understand more about why people get sick or stay healthy. The All of Us Research Program has established nationwide partnerships to build a research cohort to advance precision medicine. One million or more people living in the U.S. are being asked to share various types of health data over 10 years or more to build the largest …
Hfwh Pfac Of Influence, Julie Johns, John Chandler Ii
Hfwh Pfac Of Influence, Julie Johns, John Chandler Ii
2023 Patient Advisor Retreat
Our team is engaged with leaders from multidisciplinary departments that are working on improvement projects, ranging from marketing and messaging materials, physical plant changes, hardwiring best practices in communication and patient engagement. Our goal is to assist department leaders by improving and enhancing communication between patients, families and staff and always keeping the patient voice present on behalf of our community.
West Bloomfield Care Experience Patient And Family Advisory Council: A Year Of Change, Maureen G. Bennett, Luke Sparkman, Ioana Harland, Colleen Berson
West Bloomfield Care Experience Patient And Family Advisory Council: A Year Of Change, Maureen G. Bennett, Luke Sparkman, Ioana Harland, Colleen Berson
2023 Patient Advisor Retreat
Purpose: To enable Henry Ford Health System to provide the highest standard of safe, comprehensive and compassionate healthcare while integrating the voice of the patients and families in policy and program decision making. Scope: Providing Patient-Centered Care (Nothing about me, without me) is the best approach to improving outcomes and providing value to each patient. The Patient Advisory Council members are involved in some or all ofthe following functions as part of their advisory role: Acting as Champions of the ideal patient experience by bringing their ideas, thoughts and opinions about various topics and processes. Reviewing communications to patients and …
Macomb Care Experience Patient And Family Advisory Council - A Year Of Change, Maureen G. Bennett, Brooke Shankin, Kristi Theol, Austin Lasota
Macomb Care Experience Patient And Family Advisory Council - A Year Of Change, Maureen G. Bennett, Brooke Shankin, Kristi Theol, Austin Lasota
2023 Patient Advisor Retreat
Vision of the Committee: To create partnerships among health care practitioners, patients and families that will lead to the best outcomes and enhance the quality and safety of our health care. Objective/Purpose: Provide advice, consultation, evaluation and recommendations regarding programs, educational efforts, selected research activities and operational initiatives that affect patients and families. Provide feedback and suggestions to enhance the patient/family experience at Henry Ford Macomb Hospital. Promote respectful, effective partnerships between patients, families, healthcare providers and administration. Provide a vital link between Henry Ford Macomb Hospital and the community. Participate in educating hospital personnel about various issues from a …
Peir Ideas (Patients Engaged In Research - Inclusion, Diversity, Equity, Acceptance, And Safety), Sara Santarossa, Andrew Bossick, Karen Kippen, Christine L. M Joseph, Leah M. Copeland, Dana Murphy, Ashley Redding, Angela Murphy, Maureen G. Bennett
Peir Ideas (Patients Engaged In Research - Inclusion, Diversity, Equity, Acceptance, And Safety), Sara Santarossa, Andrew Bossick, Karen Kippen, Christine L. M Joseph, Leah M. Copeland, Dana Murphy, Ashley Redding, Angela Murphy, Maureen G. Bennett
2023 Patient Advisor Retreat
This project involves long-, mid-, and short-term objectives to address gaps in the science of engagement in research focused on development and/or assessment of instruments that measure meaningful patient engagement in research (PEIR). PEIR involves patients undertaking roles beyond those of traditional study participants by including them throughout the entire research process. Long-term objective is to develop a national model for measuring meaningful PEIR that is adaptable for all settings and catchment areas. Mid-term objective is to create the sustained engagement of a diverse group of stakeholders in the design, implementation, evaluation, and dissemination of Science of Engagement research. How …
Shift Worker Patient & Family Advisor Council (Pfac), Grace Paniccia, Jonny Russell, Salma Habash, Philip Cheng
Shift Worker Patient & Family Advisor Council (Pfac), Grace Paniccia, Jonny Russell, Salma Habash, Philip Cheng
2023 Patient Advisor Retreat
The Shift Worker Patient and Family Advisory Council (SHIFT PFAC) is an active patient engagement program aimed at improving the lives of night shift workers through their involvement and influence in our studies. We are proud to work with night shift workers as they are a group often overlooked in healthcare initiatives. We aim to work with the SHIFT PFAC to improve not only the physical health, but also the job satisfaction and overall well-being of night shift workers. The purpose of the SHIFT PFAC meetings is to foster an open dialogue where study participants can share their valuable insights, …
The Patient Perspective On Covid-19 Restrictions Lifting: A Descriptive Study Of Resuming In-Person Meetings, Sara Santarossa, Ashley Rapp, Dana Murphy, Janine Hussein
The Patient Perspective On Covid-19 Restrictions Lifting: A Descriptive Study Of Resuming In-Person Meetings, Sara Santarossa, Ashley Rapp, Dana Murphy, Janine Hussein
2023 Patient Advisor Retreat
Henry Ford’s Patient Engaged Research Center (PERC): Our mission is to translate the patient voice into evidence-based care through community engagement and world-class research methods. PERC Patient Advisor Program: PERC relies on active participation of its Patient Advisors (PAs) in the Patient Advisor Program (the Program). PAs contribute their patient and/or caregiver experience and feedback to HFH projects and initiatives to ensure care is patient-centered. COVID-19: Due to the COVID-19 pandemic, the Program adapted virtual participation in order to continue to engage PAs. Purpose: When restrictions started lifting, PERC surveyed PAs to gather feedback on resuming in-person participation
Localization Of The Gene For Men 2a, Jay B. Lichter, Michael Difilippantonio, Jingshi Wu, Diane Miller, David C. Ward, Paul J. Goodfellow, Kenneth K. Kidd
Localization Of The Gene For Men 2a, Jay B. Lichter, Michael Difilippantonio, Jingshi Wu, Diane Miller, David C. Ward, Paul J. Goodfellow, Kenneth K. Kidd
Henry Ford Hospital Medical Journal
The search for the gene that causes the multiple endocrine neoplasia type 2A (MEN 2A) syndrome is entering a new phase. Genetic linkage studies have localized the gene to the pericentromeric region of chromosome 10. The statistical portion of mapping the gene for MEN 2A is nearly complete and now classical molecular biological/gene mapping techniques will be employed. We have used fluorescence in situ hybridization to estimate the size of the MEN2A region to be about 2 to 5 mb, using some liberal assumptions; at worst the region should contain no more than about 10 mb of non-alphoid DNA. Our …
Microsurgical Lymph Node Dissection For Metastatic Asymptomatic C-Cell Carcinoma, Heinz J. Buhr, Friedrich Kallinowski, Friedhelm Raue, Christian Herfarth
Microsurgical Lymph Node Dissection For Metastatic Asymptomatic C-Cell Carcinoma, Heinz J. Buhr, Friedrich Kallinowski, Friedhelm Raue, Christian Herfarth
Henry Ford Hospital Medical Journal
In persistent, clinically inapparent medullary thyroid carcinoma, microsurgical dissection of all lymph node compartments of the neck was performed. Between August 1988 and September 1991, 28 cases (mean age 43.3 years) were treated with 38 surgical interventions. Twenty patients had the sporadic form and eight patients the familial form. Unilateral neck dissection resulted in normalization of serum calcitonin (CT) levels even after pentagastrin stimulation in two patients whereas 16 patients exhibited abnormal CT stimulation tests. Eight of ten patients who had bilateral neck dissections had positive pentagastrin test results after surgery. The main postoperative complications included loss of local cutaneous …
Cutaneous Lesion Associated With Multiple Endocrine Neoplasia Type 2a: Lichen Amyloidosis Or Notalgia Paresthetica?, O. Chabre, F. Labat, N. Pinel, F. Berthod, V. Tarel, I. Bachelot
Cutaneous Lesion Associated With Multiple Endocrine Neoplasia Type 2a: Lichen Amyloidosis Or Notalgia Paresthetica?, O. Chabre, F. Labat, N. Pinel, F. Berthod, V. Tarel, I. Bachelot
Henry Ford Hospital Medical Journal
Three patients of a French family demonstrated an association of multiple endocrine neoplasia type 2A (MEN 2A) with a pruritic scapular skin lesion. The lesions are similar to those described as familial cutaneous lichen amyloidosis in unrelated MEN 2A and medullary thyroid carcinoma families, but histological, immunohistochemical, and ultrastructural analysis of skin biopsies from each patient in the French family did not show amyloid deposition. The topography of the lesion follows dermatomes C8-D3. The patients report not only pruritus but also paresthesia and hyperalgesia, and one showed touch hypoesthesia and pain hyperesthesia in the area of the lesion. Such an …
Primary Hyperparathyroidism In Patients With Multiple Endocrine Neoplasia Type 1: Experience By A Single Surgical Team In Japan, Takao Obara, Yoshihide Fujimoto, Yukio Ito
Primary Hyperparathyroidism In Patients With Multiple Endocrine Neoplasia Type 1: Experience By A Single Surgical Team In Japan, Takao Obara, Yoshihide Fujimoto, Yukio Ito
Henry Ford Hospital Medical Journal
Nineteen patients were surgically treated for hyperparathyroidism associated with multiple endocrine neoplasia type 1 syndrome. Fourteen patients (74%) had removal of three or more parathyroid glands at the first operation, and five (26%) by removal of 2 1/2 or fewer glands. Two patients had recurrent hypercalcemia during the mean follow-up period of 65 months. One had a recurrence 10 years after subtotal parathyroidectomy. Reexploration in this patient revealed enlargement of the remaining tissue in the neck and an enlarged supernumerary gland in the aorticopulmonary window. The other patient had persistent hypercalcemia after removal of two hyperplastic parathyroid glands until after …
Medullary Thyroid Carcinoma: Australian Experience With Genetic Testing, Janet L. Ward, Valentine J. Hyland, David S. Andrew, Debbie J. Marsh, Bruce G. Robinson
Medullary Thyroid Carcinoma: Australian Experience With Genetic Testing, Janet L. Ward, Valentine J. Hyland, David S. Andrew, Debbie J. Marsh, Bruce G. Robinson
Henry Ford Hospital Medical Journal
Linkage analysis has been performed in four pedigrees with multiple endocrine neoplasia type 2A (MEN 2A) or familial medullary thyroid carcinoma (MTC) using pericentromeric chromosome 10 probes. Important information regarding carrier status has been provided in 10 individuals, many of whom would not have been identified by pentagastrin stimulation testing. We have also used pulsed field gel electrophoresis (PFGE) to link the probes H4JRBP and pMCK2 to a 150 kb fragment. Using PFGE, no evidence was found in DNA from lymphocytes of a major DNA rearrangement in two individuals affected with MEN 2A and an individual with MEN 2B compared …
Oncogene And Growth Factor Expression In Men 2 And Related Tumors, Jeffrey F. Moley, Göran K. Wallin, Michele B. Brother, Michael Kim, Samuel A. Wells Jr., Garrett M. Brodeur
Oncogene And Growth Factor Expression In Men 2 And Related Tumors, Jeffrey F. Moley, Göran K. Wallin, Michele B. Brother, Michael Kim, Samuel A. Wells Jr., Garrett M. Brodeur
Henry Ford Hospital Medical Journal
Pheochromocytomas occur sporadically or in individuals affected by inherited syndromes including multiple endocrine neoplasia (MEN) type 2A and 2B, neurofibromatosis, and the von Hippel-Lindau syndrome (vHL). Medullary thyroid carcinomas (MTCs) also occur sporadically or as part of MEN 2A, MEN 2B, and familial MTC. Little is known of the molecular genetic background of these tumors. We have shown previously that activation of the N-ras, H-ras, and K-ras oncogenes does not occur in these tumors, but that deletions of the short arm of chromosome 1 are extremely common (> 60%) and may indicate loss of a suppressor gene in the chromosomal …
Mineral Metabolic Effects Of Thyroidectomy And Long-Term Outcomes In A Family With Men 2a, Henry G. Bone Iii, Leonard J. Deftos, William H. Snyder, Charles Y. C. Pak
Mineral Metabolic Effects Of Thyroidectomy And Long-Term Outcomes In A Family With Men 2a, Henry G. Bone Iii, Leonard J. Deftos, William H. Snyder, Charles Y. C. Pak
Henry Ford Hospital Medical Journal
We have followed a family with multiple endocrine neoplasia type 2A for 18 years. Four members have undergone total thyroidectomy for medullary thyroid carcinoma or C-cell hyperplasia, and one has required bilateral adrenalectomy for pheochromoctyoma. None has developed hypercalcemic hyperparathyroidism, although parathyroid hormone levels were relatively high prethyroidectomy and fell postoperatively in the patients with high calcitonin levels. In three of the four cases, intestinal calcium absorption decreased following thyroidectomy.
Statistical Analysis Of Histomorphological Findings In Medullary Thyroid Carcinoma: Distinction Between The Different Familial Forms Of The Disease, B. Franc, M. Rosenberg-Bourgin, B. Auvert, B. Caillou, N. Dutrieux-Berger, J. Floquet, M. Houcke-Lecomte, E. Justrabo, F. Labat-Moleur, M. F. Le Bodic, A. Pages, M. Patey, G. Viennet, F. Vilde, J. P. Saint-Andre
Statistical Analysis Of Histomorphological Findings In Medullary Thyroid Carcinoma: Distinction Between The Different Familial Forms Of The Disease, B. Franc, M. Rosenberg-Bourgin, B. Auvert, B. Caillou, N. Dutrieux-Berger, J. Floquet, M. Houcke-Lecomte, E. Justrabo, F. Labat-Moleur, M. F. Le Bodic, A. Pages, M. Patey, G. Viennet, F. Vilde, J. P. Saint-Andre
Henry Ford Hospital Medical Journal
A multifactorial analysis of morphological findings was performed on 153 cases of medullary thyroid carcinoma (MTC). The aim of the study was to utilize histological criteria to discriminate between MTC associated with multiple endocrine neoplasia type 2A (MEN 2A) and that associated with the inherited MTC only syndrome. The presence of fusiform cells associated with several other markers seemed to he more predictive of MEN 2A. A comparison of inherited MTC only and sporadic MTC only showed fusiform cells to be significantly less common in inherited MTC only. These results suggest that the inherited MTC only syndrome is a distinct …
Genetics Of The Multiple Endocrine Neoplasia Type 2b Syndrome, Charles E. Jackson, Robert A. Norum
Genetics Of The Multiple Endocrine Neoplasia Type 2b Syndrome, Charles E. Jackson, Robert A. Norum
Henry Ford Hospital Medical Journal
Multiple endocrine neoplasia type 2B (MEN 2B) is similar to MEN 2A in that both autosomal dominant syndromes include medullary thyroid cancers and pheochromocytomas. It is distinct in that MEN 2B patients have much earlier age of onset with more aggressive tumors and mucosa/neuromas of the lips and tongue. The neuromas allow ascertainment generally before age 5. Studies of two and three generations of 14 MEN 2B families disclosed close linkage of the MEN 2B gene to DNA markers to which MEN2A had been linked. Multipoint analysis utilizing additional results in three generations of a 15th family have disclosed a …
High-Sensitivity Serum Calcitonin Assays Applied To Screening For Thyroid C-Cell Disease In Multiple Endocrine Neoplasia Type 2a, Michael M. Kaplan, Glenn M. Stall, Timothy Cummings, Andrew Macaulay, Philippe Motté, Hubert J. Wolfe, Seymour Reichlin, Arman J. Tashjian Jr.
High-Sensitivity Serum Calcitonin Assays Applied To Screening For Thyroid C-Cell Disease In Multiple Endocrine Neoplasia Type 2a, Michael M. Kaplan, Glenn M. Stall, Timothy Cummings, Andrew Macaulay, Philippe Motté, Hubert J. Wolfe, Seymour Reichlin, Arman J. Tashjian Jr.
Henry Ford Hospital Medical Journal
Two serum calcitonin assays with sensitivities ≤ 10 pg/mL were compared to our standard radioimmunoassay (sensitivity 100 pg/mL) in multiple endocrine neoplasia type 2A (MEN 2A) screening. Values from the Nichols displacement radioimmunoassay averaged 38% higher than values from the CIS immunoradiometric assay; values from both were highly correlated, r = 0.845. In three individuals, both of the newer assays revealed abnormalities in pentagastrin tests three to four years before abnormalities were detected by the standard assay. Pentagastrin tests after total thyroidectomy were assayed by the newer methods in patients with medullary thyroid carcinoma (MTC) diagnosed at initial testing (group …
A Preliminary Analysis Of Consortium Data For Markers Tightly Linked To Multiple Endocrine Neoplasia Type 2a, J. B. Lichter, S. M. Hackleman, B. A. J. Ponder, D. Easton, S. A. Narod, G. M. Lenoir, R. F. Gagel, N. E. Simpson, E. Gardner, P. J. Goodfellow, S. Takai, A. J. Pakstis, K. K. Kidd
A Preliminary Analysis Of Consortium Data For Markers Tightly Linked To Multiple Endocrine Neoplasia Type 2a, J. B. Lichter, S. M. Hackleman, B. A. J. Ponder, D. Easton, S. A. Narod, G. M. Lenoir, R. F. Gagel, N. E. Simpson, E. Gardner, P. J. Goodfellow, S. Takai, A. J. Pakstis, K. K. Kidd
Henry Ford Hospital Medical Journal
We have analyzed DNA marker typing data contributed by six independent groups to estimate the pairwise genetic distances between these markers and the locus for multiple endocrine neoplasia type 2A (MEN 2A). We used LIPED to calculate these distances for female, male, and sex-average linkage maps and to determine the corresponding LOD scores. The preliminary analyses of this large data set (89 MEN 2A families and five non-MEN 2A references families, with 1,934 total individuals) are reported here. These refined estimates of the genetic map in this region will aid in the assignment of presymptomatic diagnoses. This study clearly points …
Surgical Approach Of Synchronous Medullary Thyroid Carcinoma And Pheochromocytoma In Men 2 Syndrome, Georg F. W. Scheumann, Henning Dralle
Surgical Approach Of Synchronous Medullary Thyroid Carcinoma And Pheochromocytoma In Men 2 Syndrome, Georg F. W. Scheumann, Henning Dralle
Henry Ford Hospital Medical Journal
In cases with concurrent medullary thyroid carcinoma (MTC) and pheochromocytoma, discussion regarding a one-stage versus two-stage treatment strategy approach remains open. From 1975 to 1990, 11 of 25 multiple endocrine neoplasia type 2 (MEN 2) patients presented with biendocrinopathies or triendocrinopathies synchronously. All patients were treated surgically and followed subsequently in our hospital. Of the group of nine patients with concurrent MTC and pheochromocytoma, five were treated in one-stage and four in two-stage procedures. No patient had major complications intraoperatively. For the two-stage group, the total hospital stay (preoperatively and postoperatively) averaged 35 days. For the one-stage group, the total …
Pdn-21 (Katacalcin) And Chromogranin A: Tumor Markers For Medullary Thyroid Carcinoma, Friedhelm Raue, Eberhard Blind, Andreas Grauer
Pdn-21 (Katacalcin) And Chromogranin A: Tumor Markers For Medullary Thyroid Carcinoma, Friedhelm Raue, Eberhard Blind, Andreas Grauer
Henry Ford Hospital Medical Journal
The malignant C-cell releases several markets of potential clinical significance into the circulation. To determine the usefulness of these markers for management of medullary thyroid carcinoma (MTC), it is necessary to compare the usefulness of these markers with calcitonin (CT), the classical tumor marker for MTC. Measurement of serum concentrations of the peptide PDN-21 (katacalcin), a carboxyterminal cleavage product of procalcitonin. showed a high correlation with serum CT levels (r = 0.99, P < 0.01, n = 65 patients with MTC). The presence of equimolar concentrations of CT and PDN-21 (CT/PDN-21 molar ratio = 0.95 ± 0.33) indicates the peptide is cosecreted with CT. Stimulation of CT release by intravenous pentagastrin was associated with a parallel increase of PDN-21, providing further evidence of cosecretion of these two peptides. Finally, measurement of either PDN-21 or CT in selective venous catheterization specimens was useful for localization of MTC. Chromogranin A (CgA) levels were also measured in patients with MTC. Circulating levels were elevated in most patients with advanced disease. There was a moderate correlation between CgA and CT serum levels (r = 0.87, P < 0.01. n = 61 patients with MTC). Pentagastrin did not stimulate CgA, and the long half-life of CgA in the circulation did not make it possible to use this peptide for tumor localization by selective venous catheterization. We conclude that measurement of PDN-21 provides an independent assay system for diagnosis, localization, and postoperative management of MTC. whereas CgA measurement is not useful in early diagnosis of MTC and is of limited value for localization or management of progressive disease.
Patterns Of Neoplasia In C-Mos Transgenic Mice And Their Relevance To Multiple Endocrine Neoplasia, Nicholas Schulz, Friedrich Propst, Michael M. Rosenberg, R. Ilona Linnoila, Richard S. Paules, Douglas Schulte, George F. Vande Woude
Patterns Of Neoplasia In C-Mos Transgenic Mice And Their Relevance To Multiple Endocrine Neoplasia, Nicholas Schulz, Friedrich Propst, Michael M. Rosenberg, R. Ilona Linnoila, Richard S. Paules, Douglas Schulte, George F. Vande Woude
Henry Ford Hospital Medical Journal
We have previously described a neurological phenotype for transgenic mice carrying the c-Mos proto-oncogene. Pheochromocytomas and C-cell thyroid neoplasms occur in these transgenic lines in patterns that are similar to those seen in multiple endocrine neoplasia type 2 (MEN 2). Characterization of the pathological lesions via immunohistochemistry underscores similarities between MEN 2 and these transgenic mice. When transgenic mice that do not display the MEN 2 phenotype are crossed to a different background, the progeny display the MEN 2 phenotype. Thus the interaction of the background with the transgene is such that it can suppress tumor information. This observation bears …
Sublocalization Of The Multiple Endocrine Neoplasia Type 1 Gene, Catharina Larsson, Gunther Weber, Marie Janson
Sublocalization Of The Multiple Endocrine Neoplasia Type 1 Gene, Catharina Larsson, Gunther Weber, Marie Janson
Henry Ford Hospital Medical Journal
Tumorigenesis in multiple endocrine neoplasia type 1 (MEN 1) involves the unmasking of a recessive mutation at the MEN 1 locus which has been mapped to chromosomal region 11q11-13. By analyzing 58 DNA markers on a panel of radiation-reduced somatic cell hybrids, the region encompassing the MEN 1 gene was divided into nine subregions. Pulsed field gel electrophoresis analysis of markers within subgroups showed that the recombination rate around the MEN 1 locus is high. Combined linkage analysis in MEN 1 families and deletion mapping in MEN 1-related tumors suggest the MEN 1 gene is located centromeric to D11S807 and …